April 9, 2020
Zeria Pharmaceutical is holding continued discussions with Japanese regulatory authorities over its iron deficiency anemia drug Ferinject (ferric carboxymaltose), a spokesperson told Jiho on April 8, after the drug maker skipped its listing for the fourth time since its approval...read more